(1)
Surrogate Parameters, Instead of the Genetic Profile, for Recurrence Risk Evaluation in #x201C;Early-Stage Breast Cancer Cases#x201D; In a Middle #x2013; Income Country Like Argentina. GJMR 2022, 22 (F3), 27-33.